Anti-1-methyladenosine (m1A) antibody [EPR-19836-208]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(7 Publications)
Rabbit Recombinant Monoclonal 1-Methyladenosine antibody. Suitable for IP, ELISA, Dot and reacts with Modified Nucleic Acid, Modified Amino Acid samples. Cited in 7 publications.
View Alternative Names
m1A
- IP
Collaborator
Immunoprecipitation - Anti-1-methyladenosine (m1A) antibody [EPR-19836-208] (AB208196)
m1A was immunoprecipitated from 20 μg of HeLa (Human cervix adenocarcinoma epithelial cell) polyA+ RNA with 10 μg of ab208196 and 40 μL of Protein G dynabeads per sample (the IP buffer was 50mM Tris-HCl pH 7.4, 150mM NaCl, and 0.1% NP-40). The amount of m1A was quantified relative to the level of G by LC-MS/MS with electrospray ionization and in positive ionization mode, and compared to the level of m6A/G in the same samples. Error bars represent technical replicate injections of the same sample in mass spec.
All lanes:
Immunoprecipitation - Anti-1-methyladenosine (m1A) antibody [EPR-19836-208] (ab208196)
false
This image is courtesy of Dr Sigrid Nachtergaele, University of Chicago.
- ELISA
Supplier Data
ELISA - Anti-1-methyladenosine (m1A) antibody [EPR-19836-208] (AB208196)
BSA-conjugated m1A (modified) and A (unmodified) nucleosides were coated onto wells of a 96 well plate. ELISA was performed on 1.0 μg/ml of antigen using ab208196 at a concentration range of 0.005-4.000 μg/ml followed by Goat Anti-Rabbit IgG (H+L) alkaline phosphatase conjugated secondary antibody at 1/2500 dilution.
- IP
Supplier Data
Immunoprecipitation - Anti-1-methyladenosine (m1A) antibody [EPR-19836-208] (AB208196)
The IP was performed in a U-bottom non-adsorbing propylene 96-well plate.
ab208196 (0.2 μg) was coated into Dynabeads® sheep-anti-rabbit IgG (50 μl) for 1h at RT.
Unmodified/modified oligonucleotides (5 μM) were added to samples containing the antibody/bead complexes and incubated with agitation for 1 hour at RT.
After washing, Peroxidase-conjugated Streptavidin was incubated at 1/1000 dilution with agitation for 1 hour at RT.
ECL substrate was then added and the results read in a non-transparent 96-well plate with a digital detector and analyzed using ImageJ.
Lane 1 : Buffer only.
Lane 2 : Modified oligonucleotide (5 μM), 5' Biotin-mN.mN.mN.mN.mN.[m1A].mN.mN.mN.mN.mN 3'
Lane 3 : Unmodified oligonucleotide (5 μM), 5' Biotin-mN.mN.mN.mN.mN.[A]*.mN.mN.mN.mN.mN 3'
N - equimolar mixture of (A/U/G/C)
m - 2'O methyl protection
* - phosphorothioate protection
Blocking buffer and concentration : 5% NFDM/TBST
Dilution buffer and concentration : TBST/0.1% Triton X-100/1 mM EDTA
All lanes:
Immunoprecipitation - Anti-1-methyladenosine (m1A) antibody [EPR-19836-208] (ab208196)
true
- Dot
Collaborator
Dot Blot - Anti-1-methyladenosine (m1A) antibody [EPR-19836-208] (AB208196)
Dot blot of total RNA using ab208196 at 2 ug/mL. The Amersham Hybond N+ membrane was pre-spotted with 500 250 125 63 and 32 ng/dot of HeLa total RNA and 500ng of an unmodified RNA probe. The membrane was then blocked with 5% BSA in TBS with 0.1% Tween-20. Followed by blotting with anti-m1A ab208196 or ab208196 together with 100uM of free m1A nucleoside in the same blocking solution to inhibit m1A binding. A goat anti-rabbit HRP was used as the secondary antibody at 1 : 5000 dilution. Methylene blue stain was used to verify RNA loading.
This image is courtesy of Dr Sigrid Nachtergaele, University of Chicago.
- Dot
Lab
Dot Blot - Anti-1-methyladenosine (m1A) antibody [EPR-19836-208] (AB208196)
Primary antibody dilution : 1/500
Secondary antibody : Goat Anti-Rabbit IgG (H+L) Peroxidase conjugated
Secondary antibody dilution : 1/20000
Blocking buffer and dilution buffer : AdvanBlockTM Chemi Blocking buffer
Input : HeLa total RNA 0.5 μg per Dot
Competitive nucleosides : m1A m2A m2.2G
Exposure time : 37 seconds
Related conjugates and formulations (1)
-
Anti-1-methyladenosine (m1A) antibody [EPR-19836-208] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
1-methyladenosine plays a significant role in the stability and function of tRNA and rRNA molecules. This modification influences the proper folding and functionality of these RNA types ensuring accurate translation processes within the ribosome. 1-methyladenosine is part of complex interplay with different enzymes including methyltransferases that catalyze the addition of methyl groups. These enzymes are integral in maintaining the methylation pattern critical for cell homeostasis and function.
Pathways
RNA methylation is closely involved in gene expression regulations and protein synthesis pathways. m1A is important in pathways like the translation initiation process which requires precise RNA modifications for ribosomal function. Proteins such as methyltransferases are linked with m1A through these pathways helping transfer methyl groups to RNA molecules. This process affects downstream biological effects linked to cellular growth and replication.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Cell & bioscience 14:92 PubMed39004750
2024
Applications
Dot
Species
Rat
Nucleic acids research 52:2273-2289 PubMed38118002
2023
Applications
Dot
Species
Human
Acta pharmaceutica Sinica. B 13:4840-4855 PubMed38045055
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:2165 PubMed35444240
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 22: PubMed34502037
2021
Applications
Unspecified application
Species
Unspecified reactive species
RNA biology 17:1116-1124 PubMed32116132
2020
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 10:5126 PubMed31719534
2019
Applications
Unspecified application
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com